
24 articles analyzed · 3 sources · 5 key highlights
The Artemis III mission will now focus on orbital tests rather than a lunar landing, with NASA adding two new missions in 2028 as the program undergoes a major strategic overhaul.
Restricting two amino acids found in animal protein triggered dramatic increases in calorie burning in mice, with energy expenditure rivaling constant cold exposure—without reducing food intake or increasing activity.
Human neurons cultured on a chip were successfully programmed to play a first-person shooter game, bringing biological computing closer to practical applications.
Astronomers found a fully-formed barred spiral galaxy existing just 2 billion years after the Big Bang, challenging theories about how quickly complex galactic structures could develop.
Researchers used an iron catalyst and LED light to transform natural gas into pharmaceutical compounds, creating the hormone therapy drug dimestrol from methane for the first time.
NASA delivered disappointing news to space enthusiasts Friday, announcing it will scrap plans for a 2027 moon landing and fundamentally restructure its Artemis program. Meanwhile, researchers unveiled breakthroughs ranging from metabolism-hacking diets to brain cells playing video games, marking a day of both setbacks and surprising advances across the scientific landscape.
In a significant reversal, NASA announced that Artemis III will no longer attempt to land astronauts on the lunar surface in 2027. Instead, the mission will focus on testing critical systems—including docking procedures and space suits—in low Earth orbit. The agency is now planning two new missions for 2028 that will presumably advance toward an actual landing. The decision represents a major recalibration of America's flagship space exploration initiative. Rather than rushing to meet aggressive timelines, NASA appears to be embracing "smaller, faster steps forward," according to New Scientist's coverage. The program has faced persistent technical challenges and delays, prompting this strategic makeover that prioritizes validation over speed.
In potentially groundbreaking metabolic research, scientists have identified a dietary intervention that appears to activate the body's natural calorie-burning mechanisms without requiring exercise. By restricting two amino acids commonly found in animal protein—methionine and cysteine—researchers observed dramatic increases in energy expenditure in mice. The effect was striking: test subjects generated significantly more heat in their beige fat, with energy expenditure nearly matching that produced by constant cold exposure. Crucially, the mice didn't reduce food intake or increase activity; their bodies simply burned more calories naturally. While preliminary and conducted in animals, the findings suggest diet composition alone might trigger metabolic changes previously thought to require physical activity or environmental stressors.
The James Webb Space Telescope continues delivering surprises about the early universe. Astronomers announced the discovery of COSMOS-74706, a fully-formed barred spiral galaxy that existed just 2 billion years after the Big Bang—roughly 11.5 billion years ago. The galaxy features a stellar bar, a bright linear structure of stars and gas similar to our Milky Way's central feature. The finding challenges previous assumptions about how quickly complex galactic structures could form in the young universe. Barred spirals were thought to require billions of years of gradual evolution, yet here one stands in cosmic infancy, its sophisticated architecture already in place. Closer to home, new research suggests Saturn's largest moon Titan may have formed from a catastrophic collision between two earlier moons. This violent merger, occurring hundreds of millions of years ago, could have reshaped Saturn's entire satellite system and indirectly spawned its iconic rings. Evidence includes Titan's unusual orbit, surprisingly smooth surface, and the erratic tumbling of nearby Hyperion.
In a development that blurs the line between biology and technology, researchers successfully taught human brain cells cultured on a microchip to play the first-person shooter game Doom—and they did it in just one week. This neuron-powered computing platform can now be "easily programmed" for tasks, bringing biological computers closer to practical applications. The achievement represents more than a novelty. It demonstrates that biological neural networks can be harnessed, trained, and directed toward specific computational goals with reasonable efficiency. As conventional silicon-based computing approaches physical limits, hybrid biological systems may offer alternative pathways for certain types of processing.
Two separate advances in catalysis could reduce dependence on rare, expensive metals. Nagoya University researchers developed an iron-based photocatalyst that rivals precious metal performance while using far fewer costly chiral ligands. The system maintains precise control over three-dimensional molecular structures—critical for pharmaceutical applications—while relying on abundant, inexpensive iron. In an even more dramatic demonstration, scientists successfully converted methane—the primary component of natural gas—directly into complex pharmaceutical compounds using an iron catalyst powered by LED light. The team synthesized dimestrol, a hormone therapy drug, directly from methane for the first time. This breakthrough could transform how we view natural gas, shifting it from merely a fuel to a valuable chemical feedstock for medicine and other high-value products.
The American Heart Association issued sobering projections for cardiovascular health among U.S. women: by 2050, nearly 60% may have high blood pressure, with close to one in three women aged 22-44 already living with some form of heart disease. The forecast is driven by surging rates of hypertension, diabetes, and obesity. On a more hopeful note, researchers demonstrated that stem cell infusions from young donors can reduce frailty in older adults. Unlike lifestyle interventions—previously the only approach to addressing frailty—this therapy appears to target underlying biological causes, producing measurable improvements in mobility. The treatment represents a potential new tool for addressing age-related decline.
Today's developments underscore both the promise and complexity of modern science. NASA's Artemis delays remind us that ambitious goals often require recalibration, while discoveries in metabolism, chemistry, and biological computing demonstrate unexpected pathways to solving longstanding challenges. As researchers continue probing everything from ancient galaxies to the molecular basis of learning disabilities, the interplay between fundamental discovery and practical application remains as dynamic as ever.